Wetenschap
Nieuws uit wetenschappelijke bronnen over long covid, onze overzichten en nieuwe publicaties. Samenvattingen zijn door AI gemaakt; lees altijd de bron. Geen medisch advies.
Artikelen
-
New Phase 2 Data on Bezisterim for the Treatment of Long COVID
-
Lingering Viral Spike Protein Found in the Lungs of Long COVID Patients
-
Scientists discover why some people still can’t taste food after COVID-19
-
Scientists discover why some people still can’t taste food after COVID-19
-
BioVie shares Phase 2 bezisterim data for Long COVID treatment
-
Among Long COVID patients with the most fatigue, scores improved 8.93 points with BioVie’s drug vs 5.30 with placebo.
-
BioVie says bezisterim eased fatigue and cognitive symptoms in Long COVID subgroups
-
Will the NIH Vaccine Injury Clinic Confront the Wuhan Spike Protein as Root Cause?
-
Electroacupuncture May Retune the Vagus Nerve to Calm Long COVID Inflammation
-
Long COVID Linked to Overactive Fat-Metabolizing Enzymes That Fail to Resolve Inflammation
-
Probiotic VSL#3 Eases Long COVID Fatigue in Randomized Trial
-
This week in science: sea monsters, long COVID patients' microbiome, elephant carcasses
-
Five studies map the tangled biology of Long COVID, from lungs to gut
-
Journal retracts, republishes paper on Long COVID treatment trial
-
Can brain surgery reverse Alzheimer's? Plus, new clues about long COVID and the future of health data
-
Dundee researchers link mouth and lung bacteria to long COVID
-
Long COVID may impact bacteria in mouth, lungs: study
-
COVID-19 may damage the brain’s dopamine system, new study
-
COVID-19 May Leave a Lasting Mark on Allergy Risk, Massive Japanese Study Finds
-
Invivyd starts Phase 2 FLINTLOCK trial of VYD2311 antibody for Long COVID
-
BioVie to present Phase 2 trial results of bezi...
-
BioVie to present Long COVID and Parkinson’s trial results at American Neurological Association meeting
-
BioVie to present Long COVID and Parkinson’s trial results at American Neurological Association meeting
-
BioVie to Present New Bezisterim Findings in Parkinson’s Disease and Long COVID at the 2026 American Neurological Association Annual Meeting
-
Invivyd launches phase 2 trial of VYD2311 for long COVID By Investing.com
-
Invivyd and the SPEAR Study Group Announce Initiation of 'FLINTLOCK” Phase 2 Study of VYD2311, a Monoclonal Antibody for the Potential Treatment of Long COVID or Post-Vaccination Syndrome
Nieuwe publicaties
Recente wetenschappelijke publicaties over long covid (Europe PMC). Een preprint is nog niet beoordeeld door vakgenoten.
-
Early functional maturation of anti-Spike antibodies predicts efficient SARS-CoV-2 RNA clearance
19-10-2026 -
Development and validation of a nomogram for stratifying severe Mycoplasma pneumoniae pneumonia risk in children early
19-10-2026 -
Mycoplasma pneumoniae PCR positivity rate among children in Chengdu, China: a retrospective cross-sectional epidemiological study
19-10-2026 -
Exploring suicide among immigrant farmworkers in the United States: evidence from the National Violent Death Reporting System
19-10-2026 -
Evidence-based design of vaccine hesitancy information resources for health care providers
19-10-2026 -
A systematic review to characterize functional tic-like behaviors
19-10-2026 -
Analysis and prediction of trends in birth population and HBsAg-positive pregnant women in Zaozhuang City, 2012–2024
19-10-2026 -
Relative Brain Perfusion Differences in a Patient With Persistent Fatigue and Subjective Cognitive Symptoms: A Case Report
19-10-2026 -
Hyperbaric oxygen therapy as a potential treatment for MDD: a narrative review
19-10-2026 -
Potential association between dementia polygenic risk scores and subjective cognitive burden in a post-COVID cohort: a hypothesis-generating study
19-10-2026 -
Telehealth-related education and training: a systematic review of recent developments since the COVID-19 pandemic
19-10-2026 -
Central Nervous System Alterations in Individuals with Long COVID: A Systematic Review
19-10-2026 -
Prospective Cardiac MRI study comparing Recovered COVID-19 patients with Recovered Non-COVID-19 Viral Respiratory Infection Patients (R-COVID-CMR).
16-10-2026 -
Dysregulated complement activation in COVID-19: The Role of Soluble Complement Inhibitors.
16-10-2026 -
A retrospective epidemiological study of screening-derived solid cancer incidence proxy rates in South Korea before and after COVID-19 using Korean National Health Insurance Service data.
16-10-2026